Li-Ping Li Selected Research

Li-Ping Li Research Topics

Disease

7	Neoplasms (Cancer) 02/2021 - 07/2004
4	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2004
3	Carcinoma (Carcinomatosis) 10/2014 - 01/2012
2	Cognitive Dysfunction 05/2022 - 02/2010
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 10/2017
2	Infarction (Infarctions) 10/2014 - 09/2012
1	Contact Dermatitis (Eczema, Contact) 10/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Adenomyosis 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Heart Failure 01/2021
1	Liver Diseases (Liver Disease) 03/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Leiomyoma (Uterine Fibroids) 01/2019
1	Epilepsy (Aura) 01/2018
1	Overactive Urinary Bladder (Overactive Bladder) 11/2017
1	Kidney Neoplasms (Kidney Cancer) 10/2017
1	Oral Lichen Planus 08/2016
1	Seizures (Absence Seizure) 09/2015
1	Systemic candidiasis 01/2015
1	Candidiasis (Moniliasis) 01/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2014
1	Pathologic Processes 10/2014
1	Ischemic Stroke 04/2014
1	Pain (Aches) 01/2014
1	Brain Injuries (Brain Injury) 05/2011
1	Adenocarcinoma of Lung 02/2011
1	Multiple Myeloma 09/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 07/2007
1	Birth Weight (Birth Weights) 02/2007
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 02/2007
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 02/2007
1	Infections 12/2006
1	Lung Injury 02/2006

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
4	MicroRNAs (MicroRNA)IBA 03/2020 - 10/2014
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 09/2012
2	Pharmaceutical PreparationsIBA 05/2022 - 01/2021
2	Therapeutic UsesIBA 05/2022 - 02/2007
2	tanshinoneIBA 01/2021 - 01/2021
2	sodium bisulfide (NaHS)IBA 10/2014 - 09/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012 - 09/2010
2	Small Interfering RNA (siRNA)IBA 07/2007 - 07/2004
2	Arginine (L-Arginine)FDA Link 02/2007 - 02/2006
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2022
1	Bromodeoxyuridine (BrdU)IBA 05/2022
1	Benzo(a)pyreneIBA 02/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	imidazoleIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Polymethyl Methacrylate (Sol)IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2017
1	Interleukin-15 (Interleukin 15)IBA 08/2016
1	AntibodiesIBA 09/2015
1	Fluconazole (Zonal)FDA LinkGeneric 01/2015
1	safingol (sphinganine)IBA 01/2015
1	CystathionineIBA 10/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2014
1	Cyclin-Dependent Kinase 6IBA 10/2014
1	LyasesIBA 10/2014
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2014
1	GasotransmittersIBA 10/2014
1	AntioxidantsIBA 10/2014
1	Fetal Proteins (Fetoprotein)IBA 09/2014
1	Caspase 3 (Caspase-3)IBA 09/2012
1	Glutathione PeroxidaseIBA 09/2012
1	Malondialdehyde (Propanedial)IBA 09/2012
1	Superoxide DismutaseIBA 09/2012
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2012
1	ATP dependent 26S protease (26S proteasome)IBA 09/2010
1	Proteasome InhibitorsIBA 09/2010
1	Bortezomib (Velcade)FDA Link 09/2010
1	Protein Kinases (Protein Kinase)IBA 07/2007
1	Immunoglobulin G (IgG)IBA 12/2006
1	Immunoglobulin M (IgM)IBA 12/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2006
1	EndotoxinsIBA 02/2006
1	pimagedine (aminoguanidine)IBA 02/2006
1	SurvivinIBA 07/2004

Therapy/Procedure

3	Therapeutics 01/2021 - 07/2004
1	Drug Therapy (Chemotherapy) 01/2021
1	Transcranial Direct Current Stimulation 01/2020
1	Acupuncture Therapy 04/2014
1	Catgut 01/2014
1	Acupuncture Points (Acupuncture Point) 01/2014
1	Aftercare (After-Treatment) 02/2010